Algo version: 0.98b
CALT is listed at the NASDAQ Exchange
CALT [CALT]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CALT stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Calliditas Therapeutics 10 years ago, but if you had invested on Friday 5th of June 2020 when the price was $19.60, you would have made a profit of $21.13 per share or 107.81%

No, the average daily trading liquidity for Calliditas Therapeutics is $459 212 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Calliditas Therapeutics has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Calliditas Therapeutics to be high [1 out of 1]